PRN
vs
S
S&P TSX Composite Index (Canada)
PRN
Over the past 12 months, PRN has underperformed S&P TSX Composite Index (Canada), delivering a return of -3% compared to the S&P TSX Composite Index (Canada)'s +25% growth.
Stocks Performance
PRN vs S&P TSX Composite Index (Canada)
Performance Gap
PRN vs S&P TSX Composite Index (Canada)
Performance By Year
PRN vs S&P TSX Composite Index (Canada)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Profound Medical Corp
Glance View
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The company is headquartered in Mississauga, Ontario and currently employs 146 full-time employees. The company went IPO on 2014-09-24. The firm is commercializing TULSA-PRO, which is a technology that combines real-time magnetic resonance imaging (MRI), transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum to help preserve the patient’s natural functional abilities. The firm is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.